• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

Acuson paces growth of WDI index

Article

Profitability growth in the imaging devices segment for the second quarter of 1997 bested all other healthcare markets in a survey of corporate net income conducted by WDI Healthcare Markets Group of Hilton Head, SC, and KPMG Peat Marwick's Health

Profitability growth in the imaging devices segment for the second quarter of 1997 bested all other healthcare markets in a survey of corporate net income conducted by WDI Healthcare Markets Group of Hilton Head, SC, and KPMG Peat Marwick's Health Ventures practice of Atlanta. Most of the imaging segment's 466% increase in profit was due to sharply higher net income from ultrasound vendor Acuson, however.

Without Acuson, imaging device companies posted 22% net income growth and 18% revenue growth for the second quarter, putting the segment in the middle of the healthcare pack. Besides Acuson, the components of the index are ADAC Laboratories, ATL Ultrasound, OEC Medical Systems, Trex Medical, Lunar, EndoSonics, Fischer Imaging, Hologic, and Elscint.

Related Videos
Emerging Research at SNMMI Examines 18F-flotufolastat in Managing Primary and Recurrent Prostate Cancer
Could Pluvicto Have a Role in Taxane-Naïve mCRPC?: An Interview with Oliver Sartor, MD
New SNMMI President Cathy Cutler, PhD, Discusses Current Challenges and Goals for Nuclear Medicine
Where the USPSTF Breast Cancer Screening Recommendations Fall Short: An Interview with Stacy Smith-Foley, MD
A Closer Look at MRI-Guided Transurethral Ultrasound Ablation for Intermediate Risk Prostate Cancer
Improving the Quality of Breast MRI Acquisition and Processing
Can Fiber Optic RealShape (FORS) Technology Provide a Viable Alternative to X-Rays for Aortic Procedures?
Does Initial CCTA Provide the Best Assessment of Stable Chest Pain?
Making the Case for Intravascular Ultrasound Use in Peripheral Vascular Interventions
Can Diffusion Microstructural Imaging Provide Insights into Long Covid Beyond Conventional MRI?
Related Content
© 2024 MJH Life Sciences

All rights reserved.